ANDA 75893, held by Teva. Fluvoxamine Maleate.
As of Nov 16, 2026, ANDA 75893 (Fluvoxamine Maleate), held by Teva, was first approved by FDA on Sep 10, 2002, with 12 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 10, 2002 | Original application | Approved | None posted |
| Fluvoxamine Maleate25MG · tablet;oral | Fluvoxamine Maleate | Discontinued |
| Fluvoxamine Maleate50MG · tablet;oral | Fluvoxamine Maleate | Discontinued |
| Fluvoxamine Maleate100MG · tablet;oral | Fluvoxamine Maleate | Discontinued |
| Aug 18, 2023 | Supplement 13Labeling · Standard review | Approved | None posted |
| Aug 10, 2023 | Supplement 12Labeling · Standard review | Approved | None posted |
| Sep 10, 2009 | Supplement 10Labeling | Approved | None posted |
| Apr 15, 2009 | Supplement 11Labeling | Approved | None posted |
| Sep 18, 2008 | Supplement 9Labeling | Approved | None posted |
| Nov 28, 2007 | Supplement 7Labeling | Approved | None posted |
| Jun 27, 2007 | Supplement 6Labeling | Approved | None posted |
| Jul 24, 2006 | Supplement 5Labeling | Approved | None posted |
| May 3, 2005 | Supplement 4Labeling | Approved | None posted |
| Oct 20, 2004 | Supplement 3Labeling | Approved | None posted |
| May 18, 2004 | Supplement 2Labeling | Approved | None posted |
| Nov 20, 2003 | Supplement 1Labeling | Approved | None posted |
| Sep 10, 2002 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters